Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
354 participants
OBSERVATIONAL
2018-06-13
2021-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the ClariFix™ Cryotherapy Device in Subjects With Chronic Rhinitis
NCT03181594
ClariFix Cryoablation Clinical Study
NCT02820597
ClariFix Rhinitis RCT
NCT04154605
Multi-Treatment PNN Modulation for Chronic Rhinitis
NCT03791489
A Study of RhinAer Stylus for Treating Chronic Rhinitis
NCT06599736
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Open label
Open label registry study of patients treated with the ClariFix device for chronic rhinitis.
ClariFix
The ClariFix device is a handheld cryosurgical device which provides focal, controlled freezing to the target tissue.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ClariFix
The ClariFix device is a handheld cryosurgical device which provides focal, controlled freezing to the target tissue.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participant is able to provide consent and willing to adhere to the study visit schedule.
Exclusion Criteria
* Participant is scheduled to have additional nasal or sinus treatments and/or procedures completed within 3 months of treatment with the ClariFix device.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Arrinex, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amber U Luong, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
UT Health - The University of Texas
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Del Rey Allergy & Sinus
Bakersfield, California, United States
Del Rey Allergy & Sinus
Marina del Rey, California, United States
Sacramento, Ear, Nose, and Throat
Roseville, California, United States
UC Davis Dept of Otolaryngology
Sacramento, California, United States
Breathe Clear Institutue
Torrance, California, United States
Light ENT
Boynton Beach, Florida, United States
Ear, Nose, and Throat Associates of South Florida
Plantation, Florida, United States
North Georgia ENT
Cumming, Georgia, United States
Chicago Nasal & Sinus
Chicago, Illinois, United States
Rush University Medical Center
Chicago, Illinois, United States
Tandem Clinical Research
Marrero, Louisiana, United States
Albany ENT & Allergy
Albany, New York, United States
ENT & Allergy/Northwell Health
New York, New York, United States
Icahn School of Medicine at Mt. Sinai
New York, New York, United States
Piedmont ENT
Winston-Salem, North Carolina, United States
Bethlehem ENT
Bethlehem, Pennsylvania, United States
Texas Healthcare
Fort Worth, Texas, United States
Collin County ENT
Frisco, Texas, United States
UT Health
Houston, Texas, United States
ENT Associates of Texas
McKinney, Texas, United States
Ogden Clinic
Ogden, Utah, United States
Metropolitan ENT
Alexandria, Virginia, United States
Aurora Health System
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CT-0004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.